文献速递癫痫

难治性癫痫患者脑部SLC35A2基因体细胞变异的临床特征、神经病理与手术结局

Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene.
PubMed 文献 · Neurology · 2022-10-28

回顾性多中心研究分析47例难治性癫痫伴脑部SLC35A2体细胞变异患者,发现两种主要表型:早发性癫痫性脑病(39例)和药物难治性局灶性癫痫(8例),44/47例病理为MOGHE,术后63.8%达Engel I级,癫痫病程长和术后EEG异常降低手术成功概率。

要点

  • 脑部SLC35A2体细胞变异相关癫痫主要有两种表型:早发性癫痫性脑病和药物难治性局灶性癫痫。
  • 44/47例组织病理学诊断为MOGHE,3例结论不确定。
  • 术后63.8%达Engel I级,癫痫病程延长和术后EEG异常与手术结局较差相关。

核心结论

  • 脑部SLC35A2基因体细胞变异与两种主要临床表型(早发性癫痫性脑病和药物难治性局灶性癫痫)及MOGHE的组织病理学诊断相关。
  • 需要额外研究来阐明特定遗传变异、致痫组织中突变负荷与手术结局之间可能的相关性。

研究设计与样本

  • 回顾性多中心研究,纳入47例难治性癫痫伴脑部SLC35A2基因体细胞变异患者,进行描述性分析和经典假设检验。
  • 将显著相关的变量纳入广义线性模型。

主要发现

  • 早发性癫痫性脑病(EE)39例,以癫痫性痉挛为主要发作类型,伴中重度智力障碍;药物难治性局灶性癫痫(DR-FE)8例,认知功能正常或临界,伴特定神经心理缺陷。
  • 脑部MRI在EE患者中全部异常,在DR-FE患者中50%异常。
  • 组织病理学复核发现44/47例为伴少突胶质细胞增生的轻度皮质发育畸形(MOGHE),3例结论不确定。
  • 47例患者携带42种不同的嵌合SLC35A2变异:错义14例(33.3%)、移码13例(30.9%)、无义10例(23.8%)、框内缺失/重复4例(9.5%)、剪接变异1例(2.4%);变异等位基因频率(VAF)范围1.4%至52.6%(平均VAF 17.3±13.5)。
  • 末次随访(35.5±21.5个月)时,30例(63.8%)达Engel I级,其中26例(55.3%)为IA级;多数患者术后认知表现保持不变。

局限性

  • 需要额外研究来阐明特定遗传变异、致痫组织中突变负荷与手术结局之间可能的相关性。
  • 较低脑VAF与术后认知结局改善的相关性在回归分析中未得到证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The SLC35A2 gene, located at chromosome Xp11.23, encodes for a uridine diphosphate-galactose transporter. We describe clinical, genetic, neuroimaging, EEG, and histopathologic findings and assess possible predictors of postoperative seizure and cognitive outcome in 47 patients with refractory epilepsy and brain somatic SLC35A2 gene variants. METHODS: This is a retrospective multicenter study where we performed a descriptive analysis and classical hypothesis testing. We included the variables of interest significantly associated with the outcomes in the generalized linear models. RESULTS: Two main phenotypes were associated with brain somatic SLC35A2 variants: (1) early epileptic encephalopathy (EE, 39 patients) with epileptic spasms as the predominant seizure type and moderate to severe intellectual disability and (2) drug-resistant focal epilepsy (DR-FE, 8 patients) associated with normal/borderline cognitive function and specific neuropsychological deficits. Brain MRI was abnormal in all patients with EE and in 50% of those with DR-FE. Histopathology review identified mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy in 44/47 patients and was inconclusive in 3. The 47 patients harbored 42 distinct mosaic SLC35A2 variants, including 14 (33.3%) missense, 13 (30.9%) frameshift, 10 (23.8%) nonsense, 4 (9.5%) in-frame deletions/duplications, and 1 (2.4%) splicing variant. Variant allele frequencies (VAFs) ranged from 1.4% to 52.6% (mean VAF: 17.3 ± 13.5). At last follow-up (35.5 ± 21.5 months), 30 patients (63.8%) were in Engel Class I, of which 26 (55.3%) were in Class IA. Cognitive performances remained unchanged in most patients after surgery. Regression analyses showed that the probability of achieving both Engel Class IA and Class I outcomes, adjusted by age at seizure onset, was lower when the duration of epilepsy increased and higher when postoperative EEG was normal or improved. Lower brain VAF was associated with improved postoperative cognitive outcome in the analysis of associations, but this finding was not confirmed in regression analyses. DISCUSSION: Brain somatic SLC35A2 gene variants are associated with 2 main clinical phenotypes, EE and DR-FE, and a histopathologic diagnosis of MOGHE. Additional studies will be needed to delineate any possible correlation between specific genetic variants, mutational load in the epileptogenic tissue, and surgical outcomes.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Barba C, Blumcke I, Winawer MR, et al. Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene. Neurology. 2022. PMID: 36307217. doi:10.1212/WNL.0000000000201471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。